Literature DB >> 26363570

A Clinical Decision Rule to Identify Emergency Department Patients at Low Risk for Acute Coronary Syndrome Who Do Not Need Objective Coronary Artery Disease Testing: The No Objective Testing Rule.

Jaimi H Greenslade1, William Parsonage2, Martin Than3, Adam Scott4, Sally Aldous5, John W Pickering5, Christopher J Hammett6, Louise Cullen2.   

Abstract

STUDY
OBJECTIVE: We derive a clinical decision rule for ongoing investigation of patients who present to the emergency department (ED) with chest pain. The rule identifies patients who are at low risk of acute coronary syndrome and could be discharged without further cardiac testing.
METHODS: This was a prospective observational study of 2,396 patients who presented to 2 EDs with chest pain suggestive of acute coronary syndrome and had normal troponin and ECG results 2 hours after presentation. Research nurses collected clinical data on presentation, and the primary endpoint was diagnosis of acute coronary syndrome within 30 days of presentation to the ED. Logistic regression analyses were conducted on 50 bootstrapped samples to identify predictors of acute coronary syndrome. A rule was derived and diagnostic accuracy statistics were computed.
RESULTS: Acute coronary syndrome was diagnosed in 126 (5.3%) patients. Regression analyses identified the following predictors of acute coronary syndrome: cardiac risk factors, age, sex, previous myocardial infarction, or coronary artery disease and nitrate use. A rule was derived that identified 753 low-risk patients (31.4%), with sensitivity 97.6% (95% confidence interval [CI] 93.2% to 99.5%), negative predictive value 99.6% (95% CI 98.8% to 99.9%), specificity 33.0% (95% CI 31.1% to 35.0%), and positive predictive value 7.5% (95% CI 6.3% to 8.9%) for acute coronary syndrome. This was referred to as the no objective testing rule.
CONCLUSION: We have derived a clinical decision rule for chest pain patients with negative early cardiac biomarker and ECG testing results that identifies 31% at low risk and who may not require objective testing for coronary artery disease. A prospective trial is required to confirm these findings.
Copyright © 2015 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26363570     DOI: 10.1016/j.annemergmed.2015.08.006

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  2 in total

1.  Validation of the No Objective Testing Rule and Comparison to the HEART Pathway.

Authors:  Jason P Stopyra; Chadwick D Miller; Brian C Hiestand; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; Robert F Riley; Gregory B Russell; James W Hoekstra; Simon A Mahler
Journal:  Acad Emerg Med       Date:  2017-08-08       Impact factor: 3.451

2.  Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels.

Authors:  Martijn W Smulders; Sebastiaan C A M Bekkers; Yvonne J M van Cauteren; Anna Liefhebber; Jasper R Vermeer; Juliette Vervuurt; Marja P van Dieijen-Visser; Alma M A Mingels; Hans-Peter Brunner-La Rocca; Pieter C Dagnelie; Joachim E Wildberger; Harry J G M Crijns; Bas L J H Kietselaer
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.